Donna J. Cross

Donna J. Cross, PhD

Languages spoken: English

Academic Information

Departments Primary - Radiology & Imaging Sciences

Lab

Dr. Cross is a research associate professor at the University of Utah where she heads the Neuroimaging and Biotechnology Laboratory. Her research passion is to make a significant impact on the therapeutic and diagnostic options for neurological disorders and dementia through imaging. Her research includes investigations such as a new therapeutic approach for brain injury and neurodegeneration using microtubule-stabilizing agents as well as the use of MR-guided, focused ultrasound to treat spinal cord injury. She is an active study section participant for NIH, RSNA, and the Alzheimer's Association. Dr. Cross was the 2022/2023 president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI Brain Imaging Council (BIC).

Education History

Other Training Michigan State University
Undergraduate University of Michigan
 BSE
Graduate Training University of Michigan
 Postbaccalaureate Studies
Graduate Training University of Michigan
 Postbaccalaureate Studies
Doctoral Training University of Michigan
 PhD
Fellowship University of Washington
 Senior Fellow

Selected Publications

Journal Article

  1. Swift KN, Marzluff JM, Templeton CN, Shimizu T, Cross D (2020). Brain activity underlying American crow processing of encounters with dead conspecifics. Behavioural brain research, 385, 112546.
  2. Meabon JS, Cook DG, Yagi M, Terry GE, Cross DJ, Muzi M, Pagulayan KF, Logsdon AF, Schindler AG, Ghai V, Wang K, Fallen S, Zhou Y, Kim TK, Lee I, Banks WA, Carlson ES, Mayer C, Hendrickson RC, Raskind MA, Marshall DA, Perl DP, Keene CD, Peskind E (2020). Chronic elevation of plasma vascular endothelial growth factor-A (VEGF-A) is associated with a history of blast exposure. Journal of the neurological sciences, 417, 117049.
  3. Cross DJ, Huber BR, Silverman MA, Cline MM, Gill TB, Cross CG, Cook DG, Minoshima (2021). Intranasal Paclitaxel Alters Alzheimer's Disease Phenotypic Features in 3xTg-AD Mice. Journal of Alzheimer's disease, 83(1), 379-394.
  4. Cross CG, Payne AH, Hawryluk GW, Haag-Roeger R, Cheeniyil R, Brady D, Odéen H, Minoshima S, Cross DJ, Anzai (2021). Technical Note: Quantification of blood-spinal cord barrier permeability after application of magnetic resonance-guided focused ultrasound in spinal cord injury. Medical physics, 48(8), 4395-4401.
  5. Pendergraft LT, Marzluff JM, Cross DJ, Shimizu T, Templeton C (2021). American Crow Brain Activity in Response to Conspecific Vocalizations Changes When Food Is Present. Frontiers in physiology, 12, 766345.
  6. Komori S, Cross DJ, Mills M, Ouchi Y, Nishizawa S, Okada H, Norikane T, Thientunyakit T, Anzai Y, Minoshima (2022). Deep-learning prediction of amyloid deposition from early-phase amyloid positron emission tomography imaging. Annals of nuclear medicine, 36(10), 913-921.
  7. Andre JB, Oztek MA, Anzai Y, Wilson GJ, Mossa-Basha M, Hippe DS, Hoff MN, Cross DJ, Minoshima (2023). Evaluation of 3-dimensional stereotactic surface projection rendering of arterial spin labeling data in a clinical cohort. Journal of neuroimaging, 33(6), 933-940.
  8. Bischof GN, Cross D (2023). Brain Trauma Imaging. Journal of nuclear medicine, 64(1), 20-29.
  9. Minoshima S, Cross D, Thientunyakit T, Foster NL, Drzezga (2022). (18)F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies. Journal of nuclear medicine, 63(Suppl 1), 2S-12S.
  10. Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H, European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI (2017). Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis. European journal of nuclear medicine and molecular imaging, 44(3), 559-560.
  11. Pendergraft LT, Marzluff JM, Cross DJ, Shimizu T, Templeton C (2023). American crows that excel at tool use activate neural circuits distinct from less talented individuals. Nature communications, 14(1), 6539.
  12. Cherrier MM, Cross DJ, Higano CS, Minoshima (2018). Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer. Prostate cancer and prostatic diseases, 21(3), 394-402.
  13. Cline MM, Ostlie MA, Cross CG, Garwin GG, Minoshima S, Cross D (2017). Assessing Spatial Memory Impairment in a Mouse Model of Traumatic Brain Injury Using a Radial Water Tread Maze. Journal of visualized experiments, (125),
  14. Payne AH, Hawryluk GW, Anzai Y, Odéen H, Ostlie MA, Reichert EC, Stump AJ, Minoshima S, Cross D (2017). Magnetic resonance imaging-guided focused ultrasound to increase localized blood-spinal cord barrier permeability. Neural regeneration research, 12(12), 2045-2049.
  15. Cline MM, Yumul JC, Hysa L, Murra D, Garwin GG, Cook DG, Ladiges WC, Minoshima S, Cross D (2017). Novel application of a Radial Water Tread maze can distinguish cognitive deficits in mice with traumatic brain injury. Brain research, 1657, 140-147.
  16. Meabon JS, Huber BR, Cross DJ, Richards TL, Minoshima S, Pagulayan KF, Li G, Meeker KD, Kraemer BC, Petrie EC, Raskind MA, Peskind ER, Cook D (2016). Repetitive blast exposure in mice and combat veterans causes persistent cerebellar dysfunction. Science translational medicine, 8(321), 321ra6.

Review

  1. Minoshima S, Mosci K, Cross D, Thientunyakit (2021). Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders. Seminars in nuclear medicine, 51(3), 230-240.
  2. Minoshima S, Cross (2022). Application of artificial intelligence in brain molecular imaging. Annals of nuclear medicine, 36(2), 103-110.

Book Chapter

  1. Cross DJ, Komori S, Minoshima (2022). Artificial Intelligence for Brain Molecular Imaging. PET clinics, 17(1), 57-64.

Editorial

  1. Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H, European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI (2017). The need of standardization and of large clinical studies in an emerging indication of [(18)F]FDG PET: the autoimmune encephalitis. European journal of nuclear medicine and molecular imaging, 44(3), 353-357.